首頁 > 市場調查報告書 > 製藥

疫苗

市場調查報告書

商品編碼

1514926

治療性蛋白質和口服疫苗市場，按治療性蛋白質類型、遞送方式、應用、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Therapeutic Proteins and Oral Vaccines Market, By Therapeutic Protein Type, By Delivery Method, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日期: 2024年06月11日 | 出版商:

AnalystView Market Insights | 英文 393 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

報告要點

2023 年治療性蛋白質和口服疫苗市場規模為 2.5145 億美元，2024 年至 2032 年複合年成長率為 7.9%。

治療性蛋白質與口服疫苗市場-市場動態

個人化醫療和輕鬆預防推動治療性蛋白質和口服疫苗市場成長

使用治療性蛋白質和口服疫苗的個人化醫療和簡單的預防策略正在推動醫療保健市場的繁榮。美國癌症協會的資料顯示，CAR-T 細胞療法（一種個人化蛋白質療法）在某些白血病中實現了 80% 的緩解率。此外，世界衛生組織 2023 年的一份報告表明，口服疫苗由於其方便用戶使用性，可以將發展中國家的兒童免疫率提高 20%。個人化治療和方便的預防方法的結合正在推動治療性蛋白質和口服疫苗領域的大量投資並推動市場成長。

治療性蛋白質和口服疫苗市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 7.9% 左右的複合年成長率成長

根據治療性蛋白質類型細分，預計單株抗體將在 2023 年顯示最大的市場佔有率

根據給藥方式細分，注射劑是 2023 年的主導類型

按地區分類，北美是 2023 年的主要收入來源

治療性蛋白質和口服疫苗市場細分分析：

全球治療性蛋白質和口服疫苗市場根據治療性蛋白質類型、遞送方法、應用和地區進行細分。

根據治療蛋白質類型，市場分為六類：單株抗體、酵素、生長因子、干擾素、白血球介素和疫苗。單株抗體因其治療各種癌症和自體免疫疾病的標靶方法而在治療蛋白領域佔據主導地位。酵素在治療代謝紊亂方面越來越受到關注，而生長因子則有望在組織再生方面發揮作用。干擾素和白血球介素在免疫調節方面顯示出潛力，而疫苗，尤其是口服疫苗，正在徹底改變預防保健。

根據給藥方式，市場分為三類：注射、吸入和局部應用。由於精確的劑量控制和有效性，注射仍然是治療性蛋白質的主要遞送方法。吸入治療呼吸系統疾病越來越受到關注，而局部應用則為局部治療提供了便利。

治療性蛋白質和口服疫苗市場 - 地理洞察

由於醫療保健支出高、慢性病盛行率上升以及研究基礎設施完善等因素，北美佔比重最高。然而，在可支配收入增加、政府醫療保健計劃和大量患者人口的推動下，亞太地區等地區正在經歷快速成長。歐洲高度重視生物製藥開發，擁有穩定成長的成熟市場。由於未滿足的醫療需求和政府對醫療保健的投資不斷增加，非洲和拉丁美洲的發展中國家具有巨大的潛力。公司在這個市場上的成功將取決於他們遵守地區法規、制定適應不同經濟狀況的定價策略以及建立合作夥伴關係以確保更廣泛的可及性的能力。

治療性蛋白質與口服疫苗市場-競爭格局：

治療性蛋白質和口服疫苗市場是一個競爭激烈的舞台，安進、輝瑞和強生等老牌製藥巨頭都在爭奪主導地位。這些參與者利用其大量的研發預算來開發創新療法和口服疫苗。併購是另一項策略性舉措，例如輝瑞收購了一家領先的鐮狀細胞治療公司。此外，規模較小的生技公司不斷湧現，推出了有前景的利基解決方案，營造了一個充滿活力的環境。這些參與者與學術機構和政府機構之間的合作對於加速研究和發展至關重要。由於生物相似藥日益受到關注，競爭格局進一步加劇，生物相似藥為現有蛋白質療法提供了具有成本效益的替代品。這不僅對定價帶來壓力，也迫使企業不斷創新和差異化產品。

市場片段
- 治療性蛋白質和口服疫苗市場片段（依治療性蛋白質類型）
- 按交付方式分類的治療性蛋白質和口服疫苗市場片段
- 治療性蛋白質和口服疫苗市場片段（按應用）
- 按國家/地區分類的治療性蛋白質和口服疫苗市場片段
- 按地區分類的治療性蛋白質和口服疫苗市場片段
競爭洞察

第 3 章：治療性蛋白質和口服疫苗主要市場趨勢

治療性蛋白質和口服疫苗市場促進因素
- 市場促進因素的影響分析
治療性蛋白質和口服疫苗市場限制
- 市場限制影響分析
治療性蛋白質和口服疫苗的市場機會
治療性蛋白質與口服疫苗市場未來趨勢

第 4 章：治療性蛋白質與口服疫苗產業研究

PEST分析
波特五力分析
成長前景圖
規範架構分析

第 5 章：治療性蛋白質與口服疫苗市場：COVID-19 影響分析

COVID-19 之前的影響分析
COVID-19 後影響分析
- 表現最佳的市場區隔
- 邊際成長市場區隔
- 最寬鬆的市場區隔
- 邊際損失市場區隔

第 6 章：治療性蛋白質與口服疫苗市場格局

2023 年治療性蛋白質和口服疫苗市場佔有率分析
按主要製造商分類的故障數據
- 既有參與者分析
- 新興參與者分析

第 7 章：治療性蛋白質和口服疫苗市場 - 按治療性蛋白質類型

概述
- 按治療性蛋白質類型分類的細分市場佔有率分析
- 單株抗體
- 酵素
- 生長因子
- 干擾素
- 白血球介素
- 疫苗

第 8 章：治療性蛋白質和口服疫苗市場 - 按交付方式

概述
- 按交付方式分類的細分市場佔有率分析
- 注射
- 吸入
- 局部應用

第 9 章：治療性蛋白質和口服疫苗市場 - 按應用

概述
- 按應用分類的細分市場佔有率分析
- 癌症
- 自體免疫疾病
- 傳染性疾病
- 神經系統疾病
- 代謝紊亂
- 其他疾病

第 10 章：治療性蛋白質和口服疫苗市場 - 按地理位置

介紹
- 按地理位置分類的細分市場佔有率分析
北美洲
- 概述
- 北美治療性蛋白質和口服疫苗主要製造商
- 北美市場規模和預測（按國家）
- 北美市場規模與預測（按治療性蛋白質類型）
- 北美市場規模和預測（按交付方式）
- 北美市場規模和預測（按應用）
- 美國
- 加拿大
歐洲
- 概述
- 歐洲治療性蛋白質和口服疫苗的主要製造商
- 歐洲市場規模和預測（按國家）
- 歐洲市場規模與預測（按治療性蛋白質類型）
- 歐洲市場規模和預測（按交付方式）
- 歐洲市場規模和預測（按應用）
- 德國
- 義大利
- 英國
- 法國
- 俄羅斯
- 荷蘭
- 瑞典
- 波蘭
- 歐洲其他地區
亞太地區 (APAC)
- 概述
- 亞太地區治療性蛋白質和口服疫苗主要製造商
- 亞太地區市場規模與預測（按國家）
- 亞太地區市場規模與預測（按治療性蛋白質類型）
- 亞太地區市場規模與預測（以交付方式）
- 亞太地區市場規模與預測（按應用）
- 印度
- 中國
- 日本
- 韓國
- 澳洲
- 泰國
- 印尼
- 菲律賓
- 亞太地區其他地區
拉丁美洲
- 概述
- 拉丁美洲治療性蛋白質和口服疫苗的主要製造商
- 拉丁美洲市場規模與預測（按國家）
- 拉丁美洲市場規模與預測（按治療性蛋白質類型）
- 拉丁美洲市場規模和預測（以交付方式）
- 拉丁美洲市場規模與預測（按應用）
- 巴西
- 墨西哥
- 阿根廷
- 哥倫比亞
- 拉丁美洲其他地區
中東和非洲
- 概述
- 中東和非洲治療性蛋白質和口服疫苗的主要製造商
- 中東和非洲市場規模及預測（按國家）
- 中東和非洲市場規模及預測（按治療性蛋白質類型）
- 中東和非洲市場規模及預測（以交付方式）
- 中東和非洲市場規模及預測（按應用）
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 土耳其
- 阿爾及利亞
- 埃及
- MEA 的其餘部分

第 11 章：主要供應商分析 - 治療性蛋白質和口服疫苗產業

競爭儀表板
公司簡介
- Abbott Laboratories
- Amgen Inc.
- Biogen Inc.
- Eli Lilly and Company
- Emergent Biosolutions Inc.
- F. Hoffmann-La Roche Ltd
- Johnson & Johnson
- Lumen Bioscience Inc.
- Merck & Co., Inc.
- MigVax Ltd
- Neurelis Inc.
- Novo Nordisk A/S
- Pfizer Inc.
- Sanofi SA
- Serum Institute of India Pvt. Ltd.
- TransAlgae
- Others

第 12 章：360 度分析師視角

第 13 章：附錄

研究方法論
參考
縮寫
免責聲明
聯絡我們

簡介目錄圖表

Product Code: ANV2997

REPORT HIGHLIGHT

Therapeutic Proteins and Oral Vaccines Market size was valued at USD 251.45 Million in 2023, expanding at a CAGR of 7.9% from 2024 to 2032.

The Therapeutic Proteins and Oral Vaccines market encompasses treatments utilizing proteins and convenient oral vaccines. This growth is fueled by the rising need for these therapies, particularly in cancer, diabetes, and infectious diseases. Increased clinical trials, advancements in protein engineering, and growing government support for research are propelling the market forward. However, high manufacturing costs and stringent regulatory hurdles pose challenges. Despite these, the potential for personalized medicine using therapeutic proteins and the growing demand for needle-free vaccination present exciting market opportunities.

Therapeutic Proteins and Oral Vaccines Market- Market Dynamics

Personalized Medicine & Easy Prevention Drive Therapeutic Protein & Oral Vaccine Market Growth

Personalized medicine and easy prevention strategies using therapeutic proteins and oral vaccines are fueling a boom in the healthcare market. American Cancer Society data shows CAR-T cell therapy, a personalized protein treatment, achieving an 80% remission rate in some leukemias. Furthermore, a 2023 World Health Organization report suggests oral vaccines could raise childhood immunization rates in developing countries by 20% due to their user-friendliness. This confluence of personalized treatments and convenient preventative methods is driving substantial investment and propelling market growth within the Therapeutic Protein and Oral Vaccine sectors.

Therapeutic Proteins and Oral Vaccines Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.9% over the forecast period (2024-2032)

Based on Therapeutic Protein Type segmentation, Monoclonal Antibodies were predicted to show maximum market share in the year 2023

Based on Delivery Method segmentation, Injections were the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Therapeutic Proteins and Oral Vaccines Market- Segmentation Analysis:

The Global Therapeutic Proteins and Oral Vaccines Market is segmented based on Therapeutic Protein Type, Delivery Method, Application, and Region.

The market is divided into six categories based on Therapeutic Protein Type: Monoclonal Antibodies, Enzymes, Growth Factors, Interferons, Interleukins, and Vaccines. Monoclonal antibodies dominate the therapeutic protein segment due to their targeted approach to treating various cancers and autoimmune diseases. Enzymes are gaining traction for metabolic disorders, while growth factors hold promise in tissue regeneration. Interferons and interleukins show potential in immunomodulation, and vaccines, especially oral ones, are revolutionizing preventative care.

The market is divided into three categories based on Delivery Method: Injection, Inhalation, and Topical application. Injections remain the dominant delivery method for therapeutic proteins due to precise dosage control and effectiveness. Inhalation is gaining traction for respiratory diseases, while topical applications offer convenience for localized treatment.

Therapeutic Proteins and Oral Vaccines Market- Geographical Insights

North America holds the highest share due to factors like high healthcare expenditure, rising chronic disease prevalence, and established research infrastructure. However, regions like Asia Pacific are experiencing rapid growth fueled by increasing disposable income, government healthcare initiatives, and a large patient population. Europe, with its strong focus on biopharmaceutical development, presents a mature market with steady growth. Developing countries in Africa and Latin America offer significant potential due to unmet medical needs and growing government investments in healthcare. The success of companies in this market will depend on their ability to navigate regional regulations, develop pricing strategies that cater to varying economic landscapes, and establish partnerships to ensure wider accessibility.

Therapeutic Proteins and Oral Vaccines Market- Competitive Landscape:

The Therapeutic Proteins and Oral Vaccines market is a competitive arena with established pharmaceutical giants like Amgen, Pfizer, and Johnson & Johnson vying for dominance. These players leverage their extensive R&D budgets to develop innovative therapies and oral vaccines. Mergers and acquisitions are another strategic move, for instance, Pfizer's acquisition of a leading sickle cell therapy company. Additionally, smaller biotechnology firms are emerging with promising niche solutions, fostering a dynamic environment. Collaboration between these players, with academic institutions and government agencies, is crucial for accelerating research and development. The competitive landscape is further intensified by the growing focus on biosimilars, which offer cost-effective alternatives to established protein therapies. This not only puts pressure on pricing but also compels companies to constantly innovate and differentiate their products.

Recent Developments:

In January 2022, Amgen Inc., a biotechnology company, and Generate Biomedicines, a drug generation company, announced a research collaboration agreement to discover and create protein therapeutics for five clinical targets across various disease areas.

In November 2022, Merck & Co., Inc. announced that it would acquire Imago BioSciences, Inc., a clinical-stage biopharmaceutical company developing new medicines for the treatment of myeloproliferative neoplasms, for approximately USD 1.35 billion. Imago's lead candidate, bomedemstat, is an investigational orally available lysine-specific demethylase 1 (LSD1) inhibitor currently being evaluated in multiple Phase 2 clinical trials.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Abbott Laboratories

Amgen Inc.

Biogen Inc.

Eli Lilly and Company

Emergent Biosolutions Inc.

F. Hoffmann-La Roche Ltd

Johnson & Johnson

Lumen Bioscience Inc.

Merck & Co., Inc.

MigVax Ltd

Neurelis Inc.

Novo Nordisk A/S

Pfizer Inc.

Sanofi S.A.

Serum Institute of India Pvt. Ltd.

TransAlgae

Others

GLOBAL THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET, BY THERAPEUTIC PROTEIN TYPE- MARKET ANALYSIS, 2019 - 2032

Monoclonal Antibodies
Enzymes
Growth Factors
Interferons
Interleukins
Vaccines

GLOBAL THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET, BY DELIVERY METHOD- MARKET ANALYSIS, 2019 - 2032

Injection
Inhalation
Topical application

GLOBAL THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Cancer
Autoimmune Diseases
Infectious Diseases
Neurological Disorders
Metabolic Disorders
Other Diseases

GLOBAL THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Therapeutic Proteins and Oral Vaccines Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Therapeutic Proteins and Oral Vaccines Market Snippet by Therapeutic Protein Type
- 2.1.2. Therapeutic Proteins and Oral Vaccines Market Snippet by Delivery Method
- 2.1.3. Therapeutic Proteins and Oral Vaccines Market Snippet by Application
- 2.1.4. Therapeutic Proteins and Oral Vaccines Market Snippet by Country
- 2.1.5. Therapeutic Proteins and Oral Vaccines Market Snippet by Region
2.2. Competitive Insights

3. Therapeutic Proteins and Oral Vaccines Key Market Trends

3.1. Therapeutic Proteins and Oral Vaccines Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Therapeutic Proteins and Oral Vaccines Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Therapeutic Proteins and Oral Vaccines Market Opportunities
3.4. Therapeutic Proteins and Oral Vaccines Market Future Trends

4. Therapeutic Proteins and Oral Vaccines Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Therapeutic Proteins and Oral Vaccines Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Therapeutic Proteins and Oral Vaccines Market Landscape

6.1. Therapeutic Proteins and Oral Vaccines Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Therapeutic Proteins and Oral Vaccines Market - By Therapeutic Protein Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Therapeutic Protein Type, 2023 & 2032 (%)
- 7.1.2. Monoclonal Antibodies
- 7.1.3. Enzymes
- 7.1.4. Growth Factors
- 7.1.5. Interferons
- 7.1.6. Interleukins
- 7.1.7. Vaccines

8. Therapeutic Proteins and Oral Vaccines Market - By Delivery Method

8.1. Overview
- 8.1.1. Segment Share Analysis, By Delivery Method, 2023 & 2032 (%)
- 8.1.2. Injection
- 8.1.3. Inhalation
- 8.1.4. Topical application

9. Therapeutic Proteins and Oral Vaccines Market - By Application

9.1. Overview
- 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
- 9.1.2. Cancer
- 9.1.3. Autoimmune Diseases
- 9.1.4. Infectious Diseases
- 9.1.5. Neurological Disorders
- 9.1.6. Metabolic Disorders
- 9.1.7. Other Diseases

10. Therapeutic Proteins and Oral Vaccines Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Therapeutic Proteins and Oral Vaccines Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Therapeutic Proteins and Oral Vaccines Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Therapeutic Proteins and Oral Vaccines Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Therapeutic Proteins and Oral Vaccines Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Therapeutic Proteins and Oral Vaccines Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Therapeutic Proteins and Oral Vaccines Industry

11.1. Competitive Dashboard
11.2. Company Profiles
- 11.2.1. Abbott Laboratories
- 11.2.2. Amgen Inc.
- 11.2.3. Biogen Inc.
- 11.2.4. Eli Lilly and Company
- 11.2.5. Emergent Biosolutions Inc.
- 11.2.6. F. Hoffmann-La Roche Ltd
- 11.2.7. Johnson & Johnson
- 11.2.8. Lumen Bioscience Inc.
- 11.2.9. Merck & Co., Inc.
- 11.2.10. MigVax Ltd
- 11.2.11. Neurelis Inc.
- 11.2.12. Novo Nordisk A/S
- 11.2.13. Pfizer Inc.
- 11.2.14. Sanofi S.A.
- 11.2.15. Serum Institute of India Pvt. Ltd.
- 11.2.16. TransAlgae
- 11.2.17. Others

12. 360 Degree Analyst View

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us

簡介目錄圖表

List of Tables

TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Therapeutic Proteins and Oral Vaccines Market: Therapeutic Protein Type Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Therapeutic Protein Type
TABLE Global Therapeutic Proteins and Oral Vaccines Market, by Therapeutic Protein Type 2019-2032 (USD Million)
TABLE Therapeutic Proteins and Oral Vaccines Market: Delivery Method Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Delivery Method
TABLE Global Therapeutic Proteins and Oral Vaccines Market, by Delivery Method 2019-2032 (USD Million)
TABLE Therapeutic Proteins and Oral Vaccines Market: Application Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Application
TABLE Global Therapeutic Proteins and Oral Vaccines Market, by Application 2019-2032 (USD Million)
TABLE Therapeutic Proteins and Oral Vaccines Market: Regional snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Therapeutic Proteins and Oral Vaccines Market, by Region 2019-2032 (USD Million)
TABLE North America Therapeutic Proteins and Oral Vaccines Market, by Country, 2019-2032 (USD Million)
TABLE North America Therapeutic Proteins and Oral Vaccines Market, by Therapeutic Protein Type, 2019-2032 (USD Million)
TABLE North America Therapeutic Proteins and Oral Vaccines Market, by Delivery Method, 2019-2032 (USD Million)
TABLE North America Therapeutic Proteins and Oral Vaccines Market, by Application, 2019-2032 (USD Million)
TABLE Europe Therapeutic Proteins and Oral Vaccines Market, by Country, 2019-2032 (USD Million)
TABLE Europe Therapeutic Proteins and Oral Vaccines Market, by Therapeutic Protein Type, 2019-2032 (USD Million)
TABLE Europe Therapeutic Proteins and Oral Vaccines Market, by Delivery Method, 2019-2032 (USD Million)
TABLE Europe Therapeutic Proteins and Oral Vaccines Market, by Application, 2019-2032 (USD Million)
TABLE Asia Pacific Therapeutic Proteins and Oral Vaccines Market, by Country, 2019-2032 (USD Million)
TABLE Asia Pacific Therapeutic Proteins and Oral Vaccines Market, by Therapeutic Protein Type, 2019-2032 (USD Million)
TABLE Asia Pacific Therapeutic Proteins and Oral Vaccines Market, by Delivery Method, 2019-2032 (USD Million)
TABLE Asia Pacific Therapeutic Proteins and Oral Vaccines Market, by Application, 2019-2032 (USD Million)
TABLE Latin America Therapeutic Proteins and Oral Vaccines Market, by Country, 2019-2032 (USD Million)
TABLE Latin America Therapeutic Proteins and Oral Vaccines Market, by Therapeutic Protein Type, 2019-2032 (USD Million)
TABLE Latin America Therapeutic Proteins and Oral Vaccines Market, by Delivery Method, 2019-2032 (USD Million)
TABLE Latin America Therapeutic Proteins and Oral Vaccines Market, by Application, 2019-2032 (USD Million)
TABLE Middle East and Africa Therapeutic Proteins and Oral Vaccines Market, by Country, 2019-2032 (USD Million)
TABLE Middle East and Africa Therapeutic Proteins and Oral Vaccines Market, by Therapeutic Protein Type, 2019-2032 (USD Million)
TABLE Middle East and Africa Therapeutic Proteins and Oral Vaccines Market, by Delivery Method, 2019-2032 (USD Million)
TABLE Middle East and Africa Therapeutic Proteins and Oral Vaccines Market, by Application, 2019-2032 (USD Million)

List of Figures

FIGURE Therapeutic Proteins and Oral Vaccines Market Segmentation
FIGURE Market research methodology
FIGURE Value chain analysis
FIGURE Porter's Five Forces Analysis
FIGURE Market Attractiveness Analysis
FIGURE COVID-19 Impact Analysis
FIGURE Pre & Post COVID-19 Impact Comparision Study
FIGURE Competitive Landscape; Key company market share analysis, 2023
FIGURE Therapeutic Protein Type segment market share analysis, 2023 & 2032
FIGURE Therapeutic Protein Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Delivery Method segment market share analysis, 2023 & 2032
FIGURE Delivery Method segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Application segment market share analysis, 2023 & 2032
FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Regional segment market share analysis, 2023 & 2032
FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE North America Therapeutic Proteins and Oral Vaccines Market share and leading players, 2023
FIGURE Europe Therapeutic Proteins and Oral Vaccines Market share and leading players, 2023
FIGURE Asia Pacific Therapeutic Proteins and Oral Vaccines Market share and leading players, 2023
FIGURE Latin America Therapeutic Proteins and Oral Vaccines Market share and leading players, 2023
FIGURE Middle East and Africa Therapeutic Proteins and Oral Vaccines Market share and leading players, 2023
FIGURE North America market share analysis by country, 2023
FIGURE U.S. Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Canada Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Europe Therapeutic Proteins and Oral Vaccines Market share analysis by country, 2023
FIGURE Germany Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Spain Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Italy Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE France Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE UK Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Russia Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Netherlands Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Sweden Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Poland Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Rest of the Europe Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Asia Pacific Therapeutic Proteins and Oral Vaccines Market share analysis by country, 2023
FIGURE India Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE China Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Japan Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE South Korea Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Australia Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Thailand Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Indonesia Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Philippines Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Rest of APAC Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Latin America Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Latin America Therapeutic Proteins and Oral Vaccines Market share analysis by country, 2023
FIGURE Brazil Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Mexico Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Argentina Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Colombia Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Rest of LATAM Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Middle East and Africa Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Middle East and Africa Therapeutic Proteins and Oral Vaccines Market share analysis by country, 2023
FIGURE Saudi Arabia Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE United Arab Emirates Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Israel Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Turkey Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Algeria Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Egypt Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Rest of MEA Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)